参考文献/References:
[1] 臧丽芳.急性脑梗死rt-PA静脉溶栓治疗临床效果分析[J].药物与人,2014,27(8):135.
[2] Giuseppe M,Marcheselli S,Tosi PA.Safety and efficacy of alteplase in the treatment of acute ischemic stroke[J].Vasc Health Risk Manag,2009,5(1):397-409.
[3] 姚志国,陈会生.磁共振技术指导超急性脑梗死溶栓的研究进展[J/CD].中华脑血管病杂志(电子版),2012,6(4):185-188.
[4] Ishibashi A,Yoshitake Y,Adachi H.Investigation of effect of edaravone on ischemic stroke[J].Kurume Med J,2013,60(2):53-57.
[5] Wadiwala MF,Sonawalla A,Kamal AK.What is the role of free radical scavengers in acute stroke?[J].J Pak Med Assoc,2012,62(5):512-513.
[6] Jami MS,Salehi-Najafabadi Z,Ahmadinejad F,et al.Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress[J].Neurochem Int,2015,90(15):134-141.
[7] Ren Y,Wei B,Song X,et al.Edaravone’s free radical scavenging mechanisms of neuroprotection against cerebral ischemia: review of the literature[J].Int J Neurosci,2015,125(8):555-565.
[8] Sharma P,Sinha M,Shukla R,et al.A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke[J].Ann Indian Acad Neurol,2011,14(2):103-106.
[9] Nakase T,Yoshioka S,Suzuki A.Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke[J].BMC Neurol,2011,11:39.
[10] Ikeda S,Harada K,Ohwatashi A,et al.Effects of edaravone, a free radical scavenger, on photochemically induced cerebral infarction in a rat hemiplegic model[J].ScientificWorldJournal,2013,2013(2013):175280.
[11] Miyaji Y,Yoshimura S,Sakai N,et al.Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry[J].Neurol Med Chir(Tokyo),2015,55(3):241-247.
[12] Tsai YH,Yuan R,Huang YC,et al.Altered resting-state FMRI signals in acute stroke patients with ischemic penumbra[J].PLoS One,2014,9(8):e105117.
[13] 冯睿龙,朱沂.急性缺血性脑卒中的磁共振影像学研究进展[J].实用医学杂志,2015,31(3):341-343.
[14] Deprez N,De Herdt V,Vandersteene J,et al.Delayed intravenous thrombolysis based on MRI mismatch in posterior circulation stroke[J].Acta Neurol Belg,2014,114(2):113-115.
[15] Kim BJ,Kang HG,Kim HJ,et al.Magnetic resonance imaging in acute ischemic stroke treatment[J].Journal of stroke,2014,16(3):131-145.
[16] Roldan-Valadez E,Lopez-Mejia M.Current concepts on magnetic resonance imaging(MRI)perfusion-diffusion assessment in acute ischaemic stroke: a review & an update for the clinicians[J].Indian J Med Res,2014,140(6):717-728.
[17] 陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病,2014,21(6):330-333.
[18] Parsons MW,Christensen S,Mcelduff P,et al.Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis[J].J Cereb Blood Flow Metab,2010,30(6):1214-1225.
[19] Duong TQ.Magnetic resonance imaging of perfusion-diffusion mismatch in rodent and non-human Primate stroke models[J].Neurol Res,2013,35(5):465-469.
[20] Ahmetgjekaj I,Kabashi-Mu aj S,Lascu LC,et al.Magnetic resonance imaging criteria for thrombolysis in hyperacute cerebral infarction[J].Current health sciences journal,2015,40(2):111-115.
[21] Deguchi K,Liu N,Liu W,et al.Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia[J].J Neurosci Res,2014,92(11):1509-1519.
[22] Kikuchi K,Miura N,Kawahara KI,et al.Edaravone(radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke[J].Biomedical reports,2013,1(1):7-12.
[23] Sun YY,Morozov YM,Yang D,et al.Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke[J].PLoS One,2014,9(6):e98807.
[24] 李欣,李雯,刘凌云.依达拉奉联合rt-PA超时间窗静脉溶栓治疗急性脑梗死的疗效[J].中国老年学杂志,2013,33(14):3287-3288.
[25] Chapman SN,Mehndiratta P,Johansen MC,et al.Current perspectives on the use of intravenous recombinant tissue plasminogen activator(tPA)for treatment of acute ischemic stroke[J].Vasc Health Risk Manag,2014,10:75-87.